Loading...
Corbion N.V.
CRBN.AS•EURONEXT
Basic MaterialsChemicals - Specialty
€20.08
€0.39(1.98%)
Corbion N.V. (CRBN.AS) Financial Performance & Statements
Review Corbion N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-10.78%
↓ 10.78%
Operating Income Growth
-34.04%
↓ 34.04%
Net Income Growth
163.65%
↑ 163.65%
Operating Cash Flow Growth
11.31%
↑ 11.31%
Operating Margin
6.02%
↑ 6.02%
Gross Margin
24.49%
↑ 24.49%
Net Profit Margin
4.22%
↑ 4.22%
ROE
7.11%
↑ 7.11%
ROIC
6.99%
↑ 6.99%
Corbion N.V. (CRBN.AS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Corbion N.V. stock.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $637.10M | $705.80M | $738.00M | $770.50M |
| Cost of Revenue | $480.70M | $525.40M | $565.70M | $601.90M |
| Gross Profit | $156.40M | $180.40M | $172.30M | $168.60M |
| Gross Profit Ratio | $0.25 | $0.26 | $0.23 | $0.22 |
| R&D Expenses | $25.00M | $21.60M | $24.40M | $24.10M |
| SG&A Expenses | $90.80M | $91.30M | $93.00M | $90.90M |
| Operating Expenses | $122.80M | $112.90M | $117.40M | $115.00M |
| Total Costs & Expenses | $603.50M | $638.30M | $683.10M | $716.90M |
| Interest Income | $5.60M | $3.70M | $2.70M | $3.80M |
| Interest Expense | $9.30M | $21.90M | $12.90M | $10.90M |
| Depreciation & Amortization | $44.50M | $44.30M | $40.30M | $40.10M |
| EBITDA | $85.10M | $111.60M | $72.50M | $95.60M |
| EBITDA Ratio | $0.13 | $0.16 | $0.13 | $0.12 |
| Operating Income | $33.60M | $67.50M | $54.90M | $53.60M |
| Operating Income Ratio | $0.05 | $0.10 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$3.70M | -$22.10M | -$11.50M | -$9.00M |
| Income Before Tax | $29.90M | $45.40M | $43.40M | $44.60M |
| Income Before Tax Ratio | $0.05 | $0.06 | $0.06 | $0.06 |
| Income Tax Expense | $7.20M | $1.20M | $11.20M | $8.40M |
| Net Income | $28.50M | $44.80M | $28.10M | $38.20M |
| Net Income Ratio | $0.04 | $0.06 | $0.04 | $0.05 |
| EPS | $0.49 | $0.76 | $0.48 | $0.65 |
| Diluted EPS | $0.49 | $0.75 | $0.47 | $0.64 |
| Weighted Avg Shares Outstanding | $58.73M | $59.09M | $59.03M | $59.01M |
| Weighted Avg Shares Outstanding (Diluted) | $58.73M | $59.65M | $59.79M | $59.45M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan